HYPOTHESIS: Microsatellite instability (MSI) correlates with clinicopathologic characteristics and long-term prognosis in patients having gastric carcinoma. DESIGN: Analysis of prospectively collected data and biologic material. SETTING: Tertiary University Hospital, Policlinico "Le Scotte," Siena, Italy. PATIENTS: Two hundred fifty patients with gastric carcinoma. MAIN OUTCOME MEASURES: Five mononucleotide repeats (BAT-26, BAT-25, NR-24, NR-21, and NR-27) were analyzed in these patients. RESULTS: An MSI phenotype was identified in 63 patients (25.2%) and correlated with specific clinicopathologic characteristics. Favorable prognosis was confirmed for patients with an MSI phenotype in univariate (P < ....
Gastric cancer is one of the leading causes of cancer death worldwide, and although the incidence ha...
PURPOSE In the CLASSIC and MAGIC trials, microsatellite instability (MSI)–high status was a favorab...
We studied the presence of microsatellite instability (MSI) in a series of 108 gastric cancers (GCs)...
HYPOTHESIS: Microsatellite instability (MSI) correlates with clinicopathologic characteristics a...
BACKGROUND: The assessment of microsatellite instability (MSI) is not included yet in the routine ...
BACKGROUND: The clinical role of microsatellite instability (MSI) in gastric cancer (GC) is cont...
BACKGROUND AND AIM: A subset of gastric cancers showed high microsatellite instability (MSI-H). The ...
BACKGROUND AND OBJECTIVE: The relationship between survival in gastric cancer patients and the statu...
Background: Several associations between microsatellite instability (MSI) and other clinicopathologi...
Purpose: The different pathological characteristics and prognoses between gastric cancer patients co...
Background: Caucasian patients with microsatellite instability (MSI)-high gastric cancer (GC) may ha...
Objective: Microsatellite instability (MSI) in gastric cancer contributes to genetic complexities of...
We previously reported that the prognosis of microsatellite instability high (MSI-H) gastric cancer ...
This study investigated whether MSI status can be used as a prognostic biomarker and whether it is h...
try to screen for the microsatellite instability (MSI) phenotype in gastric cancer remains unclear. ...
Gastric cancer is one of the leading causes of cancer death worldwide, and although the incidence ha...
PURPOSE In the CLASSIC and MAGIC trials, microsatellite instability (MSI)–high status was a favorab...
We studied the presence of microsatellite instability (MSI) in a series of 108 gastric cancers (GCs)...
HYPOTHESIS: Microsatellite instability (MSI) correlates with clinicopathologic characteristics a...
BACKGROUND: The assessment of microsatellite instability (MSI) is not included yet in the routine ...
BACKGROUND: The clinical role of microsatellite instability (MSI) in gastric cancer (GC) is cont...
BACKGROUND AND AIM: A subset of gastric cancers showed high microsatellite instability (MSI-H). The ...
BACKGROUND AND OBJECTIVE: The relationship between survival in gastric cancer patients and the statu...
Background: Several associations between microsatellite instability (MSI) and other clinicopathologi...
Purpose: The different pathological characteristics and prognoses between gastric cancer patients co...
Background: Caucasian patients with microsatellite instability (MSI)-high gastric cancer (GC) may ha...
Objective: Microsatellite instability (MSI) in gastric cancer contributes to genetic complexities of...
We previously reported that the prognosis of microsatellite instability high (MSI-H) gastric cancer ...
This study investigated whether MSI status can be used as a prognostic biomarker and whether it is h...
try to screen for the microsatellite instability (MSI) phenotype in gastric cancer remains unclear. ...
Gastric cancer is one of the leading causes of cancer death worldwide, and although the incidence ha...
PURPOSE In the CLASSIC and MAGIC trials, microsatellite instability (MSI)–high status was a favorab...
We studied the presence of microsatellite instability (MSI) in a series of 108 gastric cancers (GCs)...